Latest stories on VRXA
Veraxa Biotech: Post-Merger Valuation Does Not Match The Risk
Seeking Alpha22 · bearishanalyst
VERAXA Biotech to Debut as a Publicly Traded Company Pioneering Next-Generation Cancer Therapies on June 11, 2026
GlobeNewswire78 · bullishgeneral